Lombard Odier Asset Management (USA)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,500
| Closed | -$1.88M | – | 328 |
|
|
2022
Q4 | $1.88M | Buy |
+16,500
| New | +$1.88M | 0.05% | 67 |
|
|
2020
Q4 | – | Sell |
-17,500
| Closed | -$1.36M | – | 258 |
|
|
2020
Q3 | $1.36M | Hold |
17,500
| – | – | 0.09% | 84 |
|
|
2020
Q2 | $973K | Buy |
17,500
+2,500
| +17% | +$139K | 0.07% | 114 |
|
|
2020
Q1 | $444K | Buy |
+15,000
| New | +$444K | 0.05% | 129 |
|
|
2016
Q4 | – | Sell |
-600,000
| Closed | -$10.9M | – | 236 |
|
|
2016
Q3 | $10.9M | Buy |
600,000
+250,000
| +71% | +$4.53M | 1.01% | 16 |
|
|
2016
Q2 | $5.77M | Buy |
350,000
+275,000
| +367% | +$4.53M | 0.7% | 39 |
|
|
2016
Q1 | $1.24M | Buy |
+75,000
| New | +$1.24M | 0.17% | 122 |
|
|
2014
Q3 | – | Sell |
-800,000
| Closed | -$12.7M | – | 225 |
|
|
2014
Q2 | $12.7M | Buy |
800,000
+150,000
| +23% | +$2.37M | 0.67% | 32 |
|
|
2014
Q1 | $9.83M | Buy |
+650,000
| New | +$9.83M | 0.38% | 71 |
|